Literature DB >> 6761715

Drugs with a class III antiarrhythmic action.

R S Bexton, A J Camm.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6761715     DOI： 10.1016/0163-7258(82)90020-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  6 in total

1.  Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

Authors:  G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

2.  Effects of tetraethylammonium on the action potential duration as modified by catecholamine-releasing action in guinea-pig papillary muscles.

Authors:  M Kojima; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

3.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Authors:  N M Debbas; C du Cailar; R S Bexton; J G Demaille; A J Camm; P Puech
Journal:  Br Heart J       Date:  1984-03

4.  Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors:  H Satoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

5.  Antiarrhythmic effects of DPI 201-106.

Authors:  G Scholtysik; F M Williams
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

6.  Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?

Authors:  D W Harron; D P Nicholls; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.